Impact of Clotting on Dialyzer Efficiency
Launched by UNIVERSITY HOSPITAL, GHENT · Feb 5, 2021
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
This single centre, randomized cross-over study includes ten consecutive stable chronic hemodialysis (HD) patients who experienced stable dialysis sessions during the last 4 weeks, and had no known coagulation disorder, active inflammation or malignancy. Double-needle vascular access is achieved through a native arterio-venous fistula or a well-functioning double lumen tunnelled central venous catheter. Patients are followed during 6 consecutive midweek dialysis sessions. At midweek, patients receive only 1/4th of their regular brand of Low-Molecular Weight Heparin anticoagulation at the be...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • experienced stable dialysis sessions during the last 4 weeks
- • double needle/lumen well-functioning vascular access
- Exclusion Criteria:
- • known coagulation disorder
- • active inflammation
- • malignancy
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gent, , Belgium
Patients applied
Trial Officials
Wim Van Biesen
Principal Investigator
University Hospital, Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials